Dosimetric characterization with 62 MeV protons of a silicon segmented detector for 2D dose verifications in radiotherapy

Similar documents
Dosimetric characterization with 62 MeV protons of a silicon segmented detector for 2D dose verifications in radiotherapy

COMPARISON OF RADIOBIOLOGICAL EFFECTS OF CARBON IONS TO PROTONS ON A RESISTANT HUMAN MELANOMA CELL LINE

Topics covered 7/21/2014. Radiation Dosimetry for Proton Therapy

Peak temperature ratio of TLD glow curves to investigate the spatial variation of LET in a clinical proton beam

Two-Dimensional Thermoluminescence Dosimetry System for Proton Beam Quality Assurance

5th ADAMAS Workshop at GSI December 15-16, 2016, Darmstadt, Germany

Protons Monte Carlo water-equivalence study of two PRESAGE formulations for proton beam dosimetry J. Phys.: Conf. Ser.

Dosimetric study of 2D ion chamber array matrix for the modern radiotherapy treatment verification

Monte Carlo water-equivalence study of two PRESAGE formulations for proton beam dosimetry

Verification of micro-beam irradiation

A comparison of dose distributions measured with two types of radiochromic film dosimeter MD55 and EBT for proton beam of energy 175 MeV

Dosimetry and QA of proton and heavier ion beams

Modelling the induction of cell death and chromosome damage by therapeutic protons

Dependence of the thermoluminescent high-temperature ratio (HTR) of LiF:Mg,Ti detectors on proton energy and dose

Characterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning


Active Scanning Beam 3 Checking Delivery/Dosimetry

IMRT point dose measurements with a diamond detector

MAESTRO: Methods and Advanced Equipment for Simulation and Treatment in Radiation Oncology

A new geometric and mechanical verification device for medical LINACs

Calibration of dosimeters for small mega voltage photon fields at ARPANSA

LONG TERM STABILITY OF THE PERFORMANCE OF A CLINICAL LINEAR ACCELERATOR AND Z-SCORE ASSESSEMENT FOR ABSORBED DOSE TO WATER QUANTITY

Proton and helium beams: the present and the future of light ion beam therapy

Absolute Dosimetry. Versatile solid and water phantoms. Introduction Introduction Introduction Introtro Intro Intro

STEREOTACTIC DOSE VERIFICATION PHANTOM VERSATILE STEREOTACTIC QA PHANTOMS

Multilayer Gafchromic film detectors for breast skin dose determination in vivo

PREDICTION OF ABSORBED DOSE DISTRIBUTIONS AND NEUTRON DOSE EQUIVALENT VALUES IN PROTON BEAM RADIATION THERAPY

Standard calibration of ionization chambers used in radiation therapy dosimetry and evaluation of uncertainties

Measurement of Dose to Implanted Cardiac Devices in Radiotherapy Patients

Online in vivo dosimetry in conformal radiotherapies with MOSkin detectors

6/29/2012 WHAT IS IN THIS PRESENTATION? MANAGEMENT OF PRIMARY DEVICES INVESTIGATED MAJOR ISSUES WITH CARDIAC DEVICES AND FROM MED PHYS LISTSERVS

Diode calibration for dose determination in total body irradiation

Small field diode dosimetry

Learning Objectives. Clinically operating proton therapy facilities. Overview of Quality Assurance in Proton Therapy. Omar Zeidan

Activity report from JCOG physics group

Intensity modulation techniques for spinal treatments and on-line VolumeView TM guidance

PROGRESS IN HADRONTHERAPY

Accuracy Requirements and Uncertainty Considerations in Radiation Therapy

A preliminary clinic dosimetry study for synchrotron radiation therapy at SSRF

Verification of treatment planning system parameters in tomotherapy using EBT Radiochromic Film

Traceability and absorbed dose standards for small fields, IMRT and helical tomotherapy

Joint ICTP/IAEA Advanced School on Dosimetry in Diagnostic Radiology and its Clinical Implementation May 2009

MEASUREMENT OF TMR AND PDD PROFILES IN SMALL FIELDS. SB Crowe, E Whittle, C Jones, T Kairn

Assessment of Dosimetric Functions of An Equinox 100 Telecobalt Machine

Use of Bubble Detectors to Characterize Neutron Dose Distribution in a Radiotherapy Treatment Room used for IMRT treatments

Proton Treatment. Keith Brown, Ph.D., CHP. Associate Director, Radiation Safety University of Pennsylvania

III. Proton-therapytherapy. Rome SB - 5/5 1

Protection of the contralateral breast during radiation therapy for breast cancer

Practical Reference Dosimetry Course April 2015 PRDC Program, at a glance. Version 1.0. Day 1 Day 2 Day 3 Day 4

Application(s) of Alanine

Semiflex 3D. Always perfectly oriented. 3D Thimble Ionization Chamber for Relative and Absolute Dosimetry

Skyscan 1076 in vivo scanning: X-ray dosimetry

Monte Carlo simulation of 192 Ir radioactive source in a phantom designed for brachytherapy dosimetry and source position evaluation.

Venue: IEEE NSS/MIC/RTSD Conference, Seoul, South Korea, 27 th October 2013 Workshop: NWK3/RD1 Radiation Protection and Dosimetry

A brief presentation of The TERA Foundation

Y FILMS DOSIMETR Nederland België / Belgique

Limits of Precision and Accuracy of Radiation Delivery Systems

Dose Assessment of Eye and Its Components in Proton Therapy by Monte Carlo Method

CHARACTERIZATION OF THE ELECTRON BEAM RADIATION FIELD BY CHEMICAL DOSIMETRY

Semiflex 3D. Always perfectly oriented. 3D Thimble Ionization Chamber for Relative and Absolute Dosimetry

Intensity Modulated Radiation Therapy: Dosimetric Aspects & Commissioning Strategies

A VMAT PLANNING SOLUTION FOR NECK CANCER PATIENTS USING THE PINNACLE 3 PLANNING SYSTEM *

Radiation qualities in carbon-ion radiotherapy at NIRS/HIMAC

9.7 Dosimetry Study on A p-n Junction Semiconductor Detector


Quality assurance program for prototype stereotactic system developed for Neptun 10 PC linac

IORT with mobile linacs: the Italian experience

Experimental Evaluation of Depth Dose by Exit Surface Diode Dosimeters for Off-Axis Wedged Fields in Radiation Therapy

Comparison and uncertainty evaluation of different calibration protocols and ionization chambers for low-energy surface brachytherapy dosimetry

MEASUREMENT OF THE EQUIVALENT INDIVIDUAL DOSES FOR PATIENTS IN ANGIOGRAPHY PROCEDURE AND INTERVENTIONAL RADIOLOGY WITH THERMOLUMINESCENT SYSTEMS

EXPERIMENTAL RESULTS IN PERCENTAGE DEPTH DOSE (PDD) DETERMINATION AT THE EXTENDED DISTANCES *

DOSIMETRIC COMPARISION FOR RADIATION QUALITY IN HIGH ENERGY PHOTON BEAMS

Calibration of two 90 Sr+ 90 Y dermatological applicators

SIMULATION RESPONSE OF RESISTIVE PLATE CHAMBER FOR FAST NEUTRONS USING GEANT4 MC CODE

An Active Matrix Flat Panel Dosimeter AMFPD for in-phantom dosimetric measurements

M. J. Maryanski, Three Dimensional BANG Polymer Gel Dosimeters AAPM'99, CE Course

Manik Aima, Larry A. DeWerd, Wesley S. Culberson

SOMATOM Drive System Owner Manual Dosimetry and imaging performance report

NIA MAGELLAN HEALTH RADIATION ONCOLOGY CODING STANDARD. Dosimetry Planning

The ANDANTE project: a multidisciplinary approach to neutron RBE

Can we deliver the dose distribution we plan in HDR-Brachytherapy of Prostate Cancer?

D DAVID PUBLISHING. Uncertainties of in vivo Dosimetry Using Semiconductors. I. Introduction. 2. Methodology

Recent advances in dosimetry in reference conditions for proton and light-ion beams

IMRT QUESTIONNAIRE. Address: Physicist: Research Associate: Dosimetrist: Responsible Radiation Oncologist(s)

Imaging of Scattered Radiation for Real Time Tracking of Tumor Motion During Lung SBRT

ADVANCES IN RADIATION TECHNOLOGIES IN THE TREATMENT OF CANCER

Quality assurance and credentialing requirements for sites using inverse planned IMRT Techniques

MODELLING A GAMMA IRRADIATION PROCESS USING THE MONTE CARLO METHOD

TLD as a tool for remote verification of output for radiotherapy beams: 25 years of experience

Discuss the general planning concepts used in proton planning. Review the unique handling of CTV / ITV / PTV when treating with protons

Can we hit the target? Can we put the dose where we want it? Quality Assurance in Stereotactic Radiosurgery and Fractionated Stereotactic Radiotherapy

Efficient Dosimetry for Proton Therapy

Università degli Studi di Napoli Federico II. Dipartimento di Fisica "Ettore Pancini"

IMRT QA: Point Dose Measurements or 2D Array?

Amendment No. 2. Item No. 2 (Rfx/ Event number )

Future upcoming technologies and what audit needs to address

Radiochromic film dosimetry in water phantoms

Basic dosimetric data for treatment planning system

Application of Implanted Markers in Proton Therapy. Course Outline. McLaren Proton Therapy Center Karmanos Cancer Institute McLaren - Flint

Disclosure. Outline. Machine Overview. I have received honoraria from Accuray in the past. I have had travel expenses paid by Accuray in the past.

Transcription:

Dosimetric characterization with 62 MeV protons of a silicon segmented detector for 2D dose verifications in radiotherapy C. Talamonti a*, M. Bucciolini a, L. Marrazzo a, D. Menichelli a. a) Department of Clinical Physiopathology, University of Florence, v.le Morgagni, 85-5134 Florence (Italy) and INFN, Florence division, via G. Sansone 1-519, Sesto Fiorentino (Italy). M. Bruzzi b b) Department of Energetics, University of Florence, via. Santa Marta, 3-5139 Florence (Italy) and INFN, Florence division, via G. Sansone 1-519, Sesto Fiorentino (Italy). G.A.P. Cirrone c, G. Cuttone c, P. LoJacono c. c) INFN, Laboratori Nazionali del Sud (LNS), Via Sofia 62-95123, Catania (Italy). Keywords: Silicon detector; Dosimetry, Proton radiotherapy PACS: 87.53.Qc (Proton, neutron, and heavier particle dosimetry: measurements) 87.66.Pm (radiation measurement: solid state detectors) Abstract Due to the features of the modern radiotherapy techniques, namely Intensity Modulated Radiation Therapy and proton-therapy, where high spatial dose gradient are often present, detectors to be employed for 2D dose verifications have to satisfy very narrow requirements. In particular they have to show high spatial resolution. In the framework of the European Integrated project MAESTRO (Methods and Advanced Equipment for Simulation and Treatment in Radio-Oncology, no. LSHC-CT-24-53564), a dosimetric detector adequate for 2D pre-treatment dose verifications was developed. It is a modular detector, based on a monolithic silicon segmented sensor, with a n-type implantation on an epitaxial p-type layer. Each pixel element is 2 2 mm 2 and the distance center-to-center is 3 mm. The sensor is composed of 21 21 pixels. In this paper we report the dosimetric characterization of the system with a proton beam. The sensor was irradiated with 62 MeV protons for clinical treatments at INFN-LNS Catania. The studied parameters were repeatability of a same pixel, response linearity versus absorbed dose and dose rate and dependence on field size. The obtained results are promising since the performances are within the project specifications. 1. Introduction The use of hadrons and in particular of protons in radiotherapy represents one of the major novelties in treating cancer. When crossing the matter, protons deposit most of their energy at the end of the range. As a * corresponding author: tel. +3955436616., fax+3955437993, e-mail cinzia.talamonti@unifi.it. 1

result of proton dose-distribution characteristics, the radiation oncologist can increase the dose to the tumor while reducing the dose to surrounding normal tissues, which has the potential for fewer harmful side effects, and increased tumor control. The specific features of highly conformal radiotherapy with proton beams require performing different dosimetry measurements, for which several detectors can be proposed. They can be point dosimeters, 2D or 3D dosimeters. In the European Integrated project MAESTRO novel technologies in patient alignment, organ tracking, dose calculation and dose measurement are being developed. The aim of Maestro is to develop and validate in clinical conditions the advanced equipment needed in using new techniques. The development of clinical protocols is very important to evaluate the emerging results and to ensure that the new technologies will be clinically relevant and industrially viable. MAESTRO project is also involved in the assessment of requirements that detectors have to meet and in the determination of the protocols and procedures that should be followed for their clinical validation. In the framework of this project a 2D silicon detector adequate for pre-treatment dose verifications was developed. In this work some parameters suitable for its dosimetric characterization have been measured, following the methodology and the procedures suggested by the project. 2. Materials and methods A. The detector A modular system based on a monolithic silicon segmented sensor for 2D pre-treatment dose verifications was designed. A detail description of the system is reported in Ref.s [1,2]. The main feature of the proposed device is the spatial resolution, which is the highest compared to all the commercially available 2D devices. A prototype has been assembled with a readout electronics made with discrete components [2]. The dosimetric characterization of the device with X ray beams has been reported in Ref. [3], while the dosimetric characterization with proton beams is described in this paper. B. Protocol and Procedures For clinical proton beams, the need for accurate dose distribution data, such as depth dose distributions and lateral dose profiles, is as great as for other radiation qualities used in radiation therapy. Absolute and relative proton dosimetry are performed as recommended in protocols [4]. For absolute dosimetry, protocols suggest measurements with a cylindrical or plane parallel ion chamber and Laboratori Nazionali del Sud (LNS) INFN centre at Catania makes use of an Exradin T1 cylindrical ion chamber or of the PTW parallel plate Markus chamber [5-6]. In order to reach a level of accuracy on the measured dose which can be considered as acceptable for proton treatments, the 2D detector must satisfy a number of requirements. In this work measurements have been carried out in order to assess some of the dosimetric parameters, following the MAESTRO procedures. In 2

particular, we have studied: the repeatability of the output of each pixel; the linearity of the response vs. absorbed dose; the output factors and the depth-dose distribution. The MAESTRO indications are the following: dose rate dependence <1%; response repeatability (i.e. short term precision) <.5%; maximum deviation from linearity <1% in the dose range from.1 to 2 cgy. C. The experimental setup Figure 1: CATANA proton beam line The detector was irradiated with 62 MeV proton therapeutic beam line of the CATANA [6-7] equipment at the LNS. Collimators were used in front of the detector to focus the beam. Repeatability, linearity, and depth dose measurements were performed using the collimator of 25mm diameter, while for output factor measurements collimators with diameter ranging from 25mm to 8mm were used. Figure 1 shows the CATANA beam line while figure 2 shows the experimental set up used during the beam test. Figure 2: Proton experimental setup. During the beam test the 441 channels silicon module was set in vertical position. Some slabs of PMMA were placed between the sensor box (on the right) and the beam collimator (on the left). 3. Results As an example in figures 3 and 4 the dose distribution in the transverse plane and the corresponding profiles along x and y directions are shown, in the case of a 2 mm diameter circular beam. 3

columns 2 4 6 8 1 12 14 16 18 2 2 4 7 6 rows 6 8 1 12 14 16 18 2 5 4 3 2 1-1 Signal (nc) Figure 3: Charge generated in the pixel matrix by a 2mm diameter circular field, the pitch size is 3mm. Delivered dose is D= 8 y profile for the 2 mm diameter proton field 8 x profile for the 2 mm diameter proton field 7 7 6 6 5 5 Signal (nc) 4 3 Signal (nc) 4 3 2 2 1 1 1 2 3 4 5 6 y profile (mm) 1 2 3 4 5 6 x profile (mm) Figure 4: a) Dose profile along the x-axis (raw no. 1?) for a 2 mm diameter proton beam; b) Profile along the y- axis (column no. 16?) for a 2 mm diameter proton beam. A. Repeatability Repeatability was measured by irradiating several times the detector with a fixed dose D at constant dose rate. Measurements were performed for different dose rates, in the range from.18 up to 14 Gy/min. The output voltage v n (t) of each channel (n = 1 441) is generated by integrating the pixel current i n (t) with a capacitance C = 1. nf. v n (t) values are sampled by an analog data acquisition board (DAQ) with period T.2 s: v nm =v n (m T), m=,1,2 Capacitors are discharged after these readings, so that the charge integrated during a period T is q nm = C v nm. 4

Several acquisitions q nm are performed during each irradiation j, and they are summed to obtain the response Q nj of each channel to the dose D: Q nj = Σ(q nm -q n ), q n being the dark signal measured when the beam is switched off. The sum is extended to the values sampled during the irradiation interval j. Repeatability is expressed, for each channel, by the standard deviation of the output for the Q nj irradiations: σ n = σ(q nj ). In table 1 the mean repeatability σ = <σ n >, averaged on the channels and measured with different dose rates is displayed. N,5 is the percentage of channels with σ n <.5%. Repeatability Linearity Dose rate (Gy/min) σ% N.5 d N 1 (%) (%) (%) (%).18.8 58 --- --- 2.5.2 1 1 57 6.8.2 1 --- --- 14.5 7 1 65 Table 1. Summary of repeatability and linearity tests with different proton dose rates. B. Linearity Linearity was studied by measuring the response of each detector channel Q nj to different values of the absorbed dose D j, at constant dose rate. The sensitivity S n of each pixel and the maximum deviation from linearity d n are then determined by a linear fit in the sense of minimum χ 2. In figure 5 as an example, for the central pixel of the detector, the signal as a function of the dose in the range 2-5 cgy is shown for two very different dose rate values: 2,5 Gy/min and 14 Gy/min at half Spread Out Bragg Peak. The linearity at low dose rate was investigated in the range,2-5 Gy while at the maximum dose rate the dose range was 1-5 Gy. All the channels behave in the same way, showing a good linearity of the response with the absorbed dose. The maximum deviation from linearity d=<d n > averaged on all pixels and the number of channels N 1 with maximum deviation d n lower that 1% are reported in table 1. 45 Channel no.325, linearity 4 Channel no.325, linearity 4 35 35 3 3 25 Signal(nC) 25 2 15 Signal(nC) 2 15 1 1 5 5 5 1 15 2 25 3 35 4 45 5 Dose (cgy) 5 1 15 2 25 3 35 4 45 5 Dose (cgy) 5

Figure 5: For a pixel of the detector, the signal as a function of the absorbed dose in the range 2-5 cgy is shown as an example for a) dose rate equal to 14 Gy/min and b) equal to 2.5 Gy/min. The dots are the experimental points, while the line is the linear fit. A slight difference (percentage?) between the values of the sensitivity obtained with these two data sets was observed. Anyhow further experiments are planned in order to study the dependence of the sensitivity on the dose rate. In fact, the measurement conditions were totally different in the two cases: in the first the absorbed dose range was.2-5 Gy with a very low dose rate, while in the second the absorbed dose range was 1-5 Gy with the highest possible dose rate. The sensitivity corresponding to the dose rate used in clinical treatments (4,9 Gy/min at half Spread Out Bragg Peak) is S=.75 nc/cgy. C. Output factors The output factors are defined as the ratio between the signal Q j for a field of given dimension (the diameter d j in our measurements) and the signal Q for a reference field delivering the same dose. In our experiment the reference field was a circular field of 25mm diameter. OF d = Q j / Q In figure 6 the measured output factors for the central pixel are plotted and compared with those measured at LNS using different detectors like TLD, GAF, Markus ionization chamber and a Scanditronix diode. Since during our measurement session no precise system for detector alignment was available, we have not been able to perform a measurement with th smallest field (d=5mm). Output factor measured by our dosimeter are in agreement with those obtained by other dosimeters, within the uncertainty determined by manual device positioning in these small fields. 12 1 Output factor (%) 8 6 4 Markus scanditronix diode GAF TLD MAESTRO 2 5 1 15 2 25 3 Collimator diameter (mm) 6

Figure 6: Output factors normalized to 25 mm diameter circle field. The red points are measured with MAESTRO prototype. D. Depth dose measurements The presence of a Bragg Peak in the stopping power profile permits to irradiate selectively tumors sparing the surrounding normal tissues. The full width half maximum of a typical Bragg Peak is usually of the order of 1 mm, a value completely insufficient to cover a tumor region (of the order of 2 mm for the case of the eye melanoma). In order to form a homogeneous dose distribution within the tumor volume, individual pristine beams have to be added up. Most proton therapy facilities are currently using a broad beam modulation technique where a spread-out Bragg peak (SOBP) is generated by a set of absorbers having different thickness. In this experiment, the detector was used to measure the SOBP. The signal was obtained by averaging on all pixels inside a beam with 25mm diameter. Depth of measurement is determined by the total thickness of PMMA slabs stacked in front of the silicon module. In this way we were able to reproduce the clinical CATANA spread out Bragg peak (figure 7). The red points are the MAESTRO measurements while the blue line is the peak measured with a diode embedded in the modulator. There is a good agreement between MAESTRO and CATANA data, especially in the distal region of the SOBP. At this stage it is a qualitative test, but this measurement is important since it takes into account at the same time the dependence of the detector response on dose rate, energy and radiation LET. 1.4 1.2 1 Signal (nc).8.6.4.2 5 1 15 2 25 3 depth (mm) Figure 7: Clinical Spread out Bragg peak: red points are MAESTRO measurements; blue line is from CATANA measurements (multiplied by an arbitrary factor). Conclusions 7

We designed and manufactured a modular system based on a monolithic silicon segmented sensor for 2D dose verifications in X-rays and proton therapy. The dosimetric characterization of the system presented in this paper refers to experiments performed with the CATANA clinical proton beam. Some of the pre-clinical tests prescribed by the MAESTRO protocol have been carried out and the results confirm that the detector exhibits performance within the project specifications. Repeatability tests were performed at different dose rates and the results are inside MAESTRO indication but at the lowest dose rate. The output factors are in good agreement whit those measured with ionization chamber, single diode or film, within the uncertainty determined by manual system allignment.. The measured Spread Out Bragg Peak shows a good agreement with the one measured with a single diode and the detector shows also a good linearity in the range 2-5 cgy. In the final configuration nine silicon modules will be assembled together to cover an area closes to 2 2 cm 2. Connected to a new integrated electronics the full system should be assembled and tested during 28. The new electronics is also expected to further improve the detector performances. Acknowledgements This work was performed in the framework of the European Integrated Project MAESTRO (Methods and Advanced Equipment for simulation and Treatment in radio-oncology) granted by the European Commission no. LSHC-CT-24-53564. and the INFN experiment PRIMA. Authors wish to acknowledge M. Brianzi at INFN, Florence division, for technical assistance. References 1) M. Bruzzi, M. Bucciolini, M. Casati, D. Menichelli, C. Talamonti, C. Piemonte, B. G. Svensson,, Appl. Phys. Lett. 9 (27), 17219. 2) D. Menichelli, M. Bruzzi, M. Bucciolinia, C. Talamonti, M. Casati, L. Marrazzo, M. Tesi, C. Piemonte, A. Pozza, N. Zorzi, M. Brianzi, A. De Sio,,Nucl. Inst. and Meth. A, in press, doi:1.116/j.nima.27.8.29. 3) C. Talamonti, M. Bruzzi, M. Bucciolini, L. Marrazzo and D. Menichelli, Nucl. Instr. and Meth. A, in press, doi:1.116/j.nima.27.8.225. 4) ICRU Report N59. Clinical Proton dosimetry Part I: Beam Production, Beam delivery and Measurement of Absorbed Dose. Bethesda, MD (USA) 1998. 5) L. Raffaele, G. A. P Cirrone, G. Cuttone, S. Lo Nigro, M. G. Sabini, V. Salamone, E. Egger, A. Kacperek, N. Romeo, Physica Medica 17 (21) 35. 6) G.A.P.Cirrone et al., IEEE Trans.Nucl.Sci., 51(24) 86. 7) www.lns.infn.it/catana/catana 8